title: Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia.
abstract: This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25-OH vitamin D3. No side-effects were observed. Although vitamin D1 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of long-standing remission in a patient with CMML. This 'differentiation therapy' might be considered as a possible alternative in the management of this disease.
authors.affiliation: Servei de Medicina Interna, Hospital de l'Esperança, Universitat Autònoma de Barcelona, Spain.
authors.forename: L
authors.initials: L
authors.lastname: Mellibovsky
authors.forename: A
authors.initials: A
authors.lastname: Díez
authors.forename: J
authors.initials: J
authors.lastname: Aubia
authors.forename: X
authors.initials: X
authors.lastname: Nogues
authors.forename: E
authors.initials: E
authors.lastname: Pérez-Vila
authors.forename: S
authors.initials: S
authors.lastname: Serrano
authors.forename: R R
authors.initials: RR
authors.lastname: Recker
mesh_terms: D000368:Aged; D002112:Calcifediol / Q000627:therapeutic use*; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000188:drug therapy*; D008297:Male; D012074:Remission Induction
chemical_list: D002112:Calcifediol